Primary Job Title Chief Executive Officer Primary Organization 
Arecor
Location London, England, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Female
Investor Type Number of Exits
LinkedIn View on LinkedIn
Sarah Howell has been Chief Executive Officer of Arecor since 2015.
Through her leadership, Arecor has grown significantly into a publicly listed clinical stage biopharmaceutical company. Since her appointment, Sarah has led Arecor through a period of continued growth and transformation, playing an instrumental role in progressing its proprietary
pipeline and strengthening important collaborations with global partners.
Sarah has a background in clinical and commercial pharmaceutical product development, manufacturing, supply and licensing across a range of product types and therapeutic areas, with previous senior roles in the pharmaceutical industry including Vice President CMC & Technical Development at BTG Plc., and Director of Outsourced Manufacturing at UCB-Celltech. Sarah holds a BSc in Chemistry from the University of Birmingham and a Ph.D. in Physical Organic Chemistry from the University of St Andrews.
